Hikma Pharmaceuticals Regulatory News (HIK)

Hikma Pharmaceuticals Information

Buy HIK Shares
Add HIK to Watchlist
Add HIK to Alert

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,905.00

Bid: 1,910.00

Ask: 1,911.00

Change: 0.00 (0.00%)

Spread: 1.00 (0.052%)

Open: 0.00

High: 0.00

Low: 0.00

Prev. Close: 1,905.00

Last checked at -

Transaction in Own Shares

28 Feb 2022 18:37

RNS Number : 1084D

Hikma Pharmaceuticals Plc

28 February 2022

Hikma Pharmaceuticals PLC

Share Buyback Programme

London, 28 February 2022

Hikma Pharmaceuticals PLC ("Hikma") announces today that it has purchased the following number of its ordinary shares on the London Stock Exchange and/or on BATS and/or on Chi-X trading venues from Citigroup Global Markets Limited ("Citi"). The repurchased shares will be cancelled.

	London Stock Exchange	BATS Trading Venue	Chi-X Trading Venue
Number of ordinary shares purchased:	7,108	3,686	3,638
Highest price paid (per ordinary share):	£20.0000	£20.0000	£20.2500
Lowest price paid (per ordinary share):	£19.8150	£19.8700	£19.8750
Volume weighted average price paid (per ordinary share):	£19.9572	£19.9650	£20.0467

Such purchases form part of Hikma's share buyback programme announced on 24 February 2022.

Following the settlement of the above purchases and cancellation of the purchased ordinary shares, the total number of ordinary shares in issue shall be 244,146,355 ordinary shares and the total number of ordinary shares held in treasury is 12,833,233 ordinary shares. Therefore, following the above purchases total voting rights are 231,313,122 ordinary shares.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the detailed breakdown of individual trades made by Citi on behalf of Hikma as part of the buyback programme is set out below.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

Schedule of Purchases - Individual Transactions

Date of Transaction	Time of Transaction	Number of Shares	Price Per Share (GBp)	Trading Venue	Transaction Reference Number
28/02/2022	09:18:30	117	2,025.00	CHIX	xsqApDVDfEk
28/02/2022	09:18:30	51	2,024.00	CHIX	xsqApDVDfEe
28/02/2022	09:18:30	28	2,024.00	CHIX	xsqApDVDfEg
28/02/2022	09:24:04	90	2,024.00	CHIX	xsqApDVDiMF
28/02/2022	09:24:04	41	2,024.00	CHIX	xsqApDVDiMH
28/02/2022	09:20:45	55	2,024.00	CHIX	xsqApDVDhE@
28/02/2022	09:20:45	29	2,024.00	CHIX	xsqApDVDhE0
28/02/2022	09:15:18	143	2,022.00	CHIX	xsqApDVDKcO
28/02/2022	09:12:55	91	2,021.00	CHIX	xsqApDVDIyX
28/02/2022	09:06:19	107	2,020.00	CHIX	xsqApDVDVBN
28/02/2022	09:09:14	93	2,020.00	CHIX	xsqApDVDH3P
28/02/2022	09:09:14	3	2,020.00	CHIX	xsqApDVDH3R
28/02/2022	09:11:09	95	2,017.00	CHIX	xsqApDVDJVJ
28/02/2022	09:11:09	31	2,017.00	CHIX	xsqApDVDJVL
28/02/2022	09:03:56	66	2,013.00	CHIX	xsqApDVDQhR
28/02/2022	09:03:56	50	2,013.00	CHIX	xsqApDVDQhT
28/02/2022	09:03:59	79	2,013.00	CHIX	xsqApDVDQfh
28/02/2022	08:08:56	62	2,000.00	CHIX	xsqApDVEaGi
28/02/2022	08:09:00	149	2,000.00	CHIX	xsqApDVEaKq
28/02/2022	08:26:11	124	2,000.00	XLON	xsqApDVEmdV
28/02/2022	08:26:11	37	2,000.00	XLON	xsqApDVEmcX
28/02/2022	08:26:11	95	2,000.00	CHIX	xsqApDVEmcZ
28/02/2022	08:26:11	104	2,000.00	BATE	xsqApDVEmcb
28/02/2022	08:11:04	5	2,000.00	BATE	xsqApDVEcRH
28/02/2022	08:11:04	188	2,000.00	XLON	xsqApDVEcR9
28/02/2022	08:11:04	47	2,000.00	BATE	xsqApDVEcRJ
28/02/2022	08:40:18	201	2,000.00	XLON	xsqApDVDBXk
28/02/2022	08:11:04	23	2,000.00	BATE	xsqApDVEcRB
28/02/2022	08:11:04	9	2,000.00	BATE	xsqApDVEcRD
28/02/2022	08:11:04	3	2,000.00	BATE	xsqApDVEcRF
28/02/2022	08:06:05	105	2,000.00	CHIX	xsqApDVEZoZ
28/02/2022	08:06:05	201	2,000.00	XLON	xsqApDVEZof
28/02/2022	08:09:44	83	2,000.00	BATE	xsqApDVEdR$
28/02/2022	08:09:43	9	2,000.00	BATE	xsqApDVEaaH
28/02/2022	08:09:43	17	2,000.00	BATE	xsqApDVEaaJ
28/02/2022	08:09:43	4	2,000.00	BATE	xsqApDVEaaL
28/02/2022	08:09:43	42	2,000.00	CHIX	xsqApDVEaaT
28/02/2022	08:09:43	124	2,000.00	XLON	xsqApDVEaaF
28/02/2022	08:09:43	109	2,000.00	CHIX	xsqApDVEaaV
28/02/2022	08:09:43	9	2,000.00	BATE	xsqApDVEaaN
28/02/2022	08:09:43	25	2,000.00	BATE	xsqApDVEaaP
28/02/2022	08:09:43	23	2,000.00	BATE	xsqApDVEaaR
28/02/2022	08:40:59	69	2,000.00	BATE	xsqApDVDAFc
28/02/2022	08:36:57	150	2,000.00	CHIX	xsqApDVD9ot
28/02/2022	08:40:59	131	2,000.00	XLON	xsqApDVDAFa
28/02/2022	08:40:59	64	2,000.00	BATE	xsqApDVDAFe
28/02/2022	08:36:57	118	2,000.00	BATE	xsqApDVD9ov
28/02/2022	08:40:59	122	2,000.00	CHIX	xsqApDVDAFg
28/02/2022	08:36:57	147	2,000.00	XLON	xsqApDVD9or
28/02/2022	08:06:06	138	2,000.00	BATE	xsqApDVEZpt
28/02/2022	08:45:06	69	2,000.00	XLON	xsqApDVDCrr
28/02/2022	08:32:33	98	2,000.00	CHIX	xsqApDVEqZV
28/02/2022	08:32:33	110	2,000.00	XLON	xsqApDVEqZT
28/02/2022	08:11:04	97	1,999.50	XLON	xsqApDVEcR7
28/02/2022	08:11:04	14	1,999.50	XLON	xsqApDVEcR5
28/02/2022	08:00:53	83	1,999.50	XLON	xsqApDVEisj
28/02/2022	08:06:05	93	1,999.50	XLON	xsqApDVEZob
28/02/2022	08:09:43	66	1,999.50	XLON	xsqApDVEaaD
28/02/2022	08:09:43	7	1,999.50	XLON	xsqApDVEaaB
28/02/2022	08:40:59	64	1,999.50	BATE	xsqApDVDAFW
28/02/2022	08:40:59	73	1,999.50	CHIX	xsqApDVDAFY
28/02/2022	08:40:59	131	1,999.50	XLON	xsqApDVDACR
28/02/2022	08:36:57	86	1,999.50	XLON	xsqApDVD9op
28/02/2022	08:45:06	81	1,999.50	BATE	xsqApDVDCrk
28/02/2022	08:40:59	26	1,999.50	BATE	xsqApDVDACU
28/02/2022	08:32:33	8	1,999.50	CHIX	xsqApDVEqZN
28/02/2022	08:32:33	26	1,999.50	CHIX	xsqApDVEqZP
28/02/2022	08:32:33	32	1,999.50	CHIX	xsqApDVEqZR
28/02/2022	08:16:32	59	1,999.00	XLON	xsqApDVEw$h
28/02/2022	08:16:32	80	1,999.00	XLON	xsqApDVEwyB
28/02/2022	08:16:32	82	1,999.00	XLON	xsqApDVEwyD
28/02/2022	08:16:32	159	1,998.50	XLON	xsqApDVEwyR
28/02/2022	08:11:04	159	1,998.50	BATE	xsqApDVEcRg
28/02/2022	08:11:04	164	1,998.50	BATE	xsqApDVEcRu
28/02/2022	08:16:32	100	1,998.50	XLON	xsqApDVEw$j
28/02/2022	08:12:00	127	1,998.50	BATE	xsqApDVEceY
28/02/2022	08:12:00	46	1,998.50	CHIX	xsqApDVEcea
28/02/2022	08:12:00	25	1,998.50	CHIX	xsqApDVEcec
28/02/2022	08:09:46	66	1,998.50	BATE	xsqApDVEdPN
28/02/2022	08:09:43	83	1,998.50	BATE	xsqApDVEaah
28/02/2022	08:08:49	136	1,998.50	CHIX	xsqApDVEaP7
28/02/2022	08:12:22	96	1,998.50	BATE	xsqApDVEvUQ
28/02/2022	08:12:22	44	1,998.50	CHIX	xsqApDVEvUS
28/02/2022	08:12:22	94	1,998.50	XLON	xsqApDVEvUM
28/02/2022	08:12:22	42	1,998.50	CHIX	xsqApDVEvUU
28/02/2022	08:12:00	15	1,998.00	XLON	xsqApDVEcfS
28/02/2022	08:12:00	100	1,998.00	XLON	xsqApDVEcfU
28/02/2022	08:12:00	86	1,998.00	BATE	xsqApDVEceW
28/02/2022	08:12:22	65	1,998.00	BATE	xsqApDVEvUO
28/02/2022	08:43:31	100	1,997.50	XLON	xsqApDVDDlY
28/02/2022	08:43:31	87	1,997.50	BATE	xsqApDVDDle
28/02/2022	08:43:31	98	1,997.50	CHIX	xsqApDVDDlg
28/02/2022	08:43:31	40	1,997.50	CHIX	xsqApDVDDli
28/02/2022	08:43:31	34	1,997.00	CHIX	xsqApDVDDla
28/02/2022	08:43:31	66	1,997.00	XLON	xsqApDVDDlW
28/02/2022	08:43:31	68	1,997.00	CHIX	xsqApDVDDlc
28/02/2022	08:43:31	176	1,997.00	BATE	xsqApDVDDiK
28/02/2022	08:16:34	118	1,996.50	XLON	xsqApDVEwoN
28/02/2022	08:16:55	11	1,996.50	BATE	xsqApDVEwZE
28/02/2022	08:16:55	19	1,996.50	BATE	xsqApDVEwZG
28/02/2022	08:16:55	11	1,996.50	XLON	xsqApDVEwZA
28/02/2022	08:16:55	100	1,996.50	BATE	xsqApDVEwZI
28/02/2022	08:07:01	154	1,996.50	XLON	xsqApDVEYrZ
28/02/2022	08:16:55	91	1,996.50	XLON	xsqApDVEwZC
28/02/2022	08:17:01	11	1,996.50	XLON	xsqApDVEwbp
28/02/2022	08:43:31	66	1,996.50	XLON	xsqApDVDDiR
28/02/2022	08:23:34	187	1,996.00	XLON	xsqApDVEn19
28/02/2022	08:23:34	116	1,996.00	CHIX	xsqApDVEn1B
28/02/2022	08:16:07	2	1,996.00	CHIX	xsqApDVEwAC
28/02/2022	08:16:07	90	1,996.00	CHIX	xsqApDVEwAE
28/02/2022	08:16:07	118	1,996.00	XLON	xsqApDVEwAA
28/02/2022	08:16:07	16	1,996.00	CHIX	xsqApDVEwAG
28/02/2022	08:14:25	76	1,996.00	CHIX	xsqApDVEufr
28/02/2022	08:16:36	164	1,996.00	XLON	xsqApDVEwmG
28/02/2022	08:17:01	80	1,996.00	BATE	xsqApDVEwba
28/02/2022	08:17:01	116	1,996.00	XLON	xsqApDVEwbZ
28/02/2022	08:17:01	74	1,996.00	BATE	xsqApDVEwbl
28/02/2022	08:17:01	78	1,996.00	XLON	xsqApDVEwbn
28/02/2022	08:17:01	15	1,996.00	BATE	xsqApDVEwbr
28/02/2022	08:23:34	118	1,995.50	BATE	xsqApDVEn17
28/02/2022	08:23:34	129	1,995.50	XLON	xsqApDVEn15
28/02/2022	08:14:25	125	1,995.50	XLON	xsqApDVEufp
28/02/2022	08:07:12	74	1,995.50	XLON	xsqApDVEYcS
28/02/2022	08:07:12	9	1,995.50	XLON	xsqApDVEYcU
28/02/2022	08:17:01	79	1,995.50	XLON	xsqApDVEzQU
28/02/2022	08:34:26	93	1,995.50	CHIX	xsqApDVEsQS
28/02/2022	08:22:59	83	1,995.50	XLON	xsqApDVE@bC
28/02/2022	08:34:26	128	1,995.50	BATE	xsqApDVEsQU
28/02/2022	08:12:59	42	1,995.00	BATE	xsqApDVEv@m
28/02/2022	08:12:59	64	1,995.00	BATE	xsqApDVEv@o
28/02/2022	08:14:25	122	1,995.00	XLON	xsqApDVEufn
28/02/2022	08:21:02	116	1,995.00	XLON	xsqApDVE$oi
28/02/2022	08:23:05	2	1,995.00	XLON	xsqApDVEnUu
28/02/2022	08:23:05	98	1,995.00	XLON	xsqApDVEnUw
28/02/2022	08:34:26	99	1,995.00	XLON	xsqApDVEsQE
28/02/2022	08:34:26	88	1,995.00	BATE	xsqApDVEsQJ
28/02/2022	08:34:26	133	1,995.00	XLON	xsqApDVEsQQ
28/02/2022	08:13:03	43	1,994.50	BATE	xsqApDVEvp$
28/02/2022	08:13:03	45	1,994.50	BATE	xsqApDVEvp1
28/02/2022	08:13:03	19	1,994.50	BATE	xsqApDVEvp3
28/02/2022	08:13:03	83	1,994.50	XLON	xsqApDVEvpz
28/02/2022	08:22:16	116	1,994.50	XLON	xsqApDVE@1k
28/02/2022	08:22:16	34	1,994.50	CHIX	xsqApDVE@1i
28/02/2022	08:22:16	81	1,994.50	CHIX	xsqApDVE@1e
28/02/2022	08:22:16	103	1,994.50	BATE	xsqApDVE@1g
28/02/2022	08:07:31	163	1,994.50	XLON	xsqApDVEbHm
28/02/2022	08:21:02	52	1,994.50	XLON	xsqApDVE$og
28/02/2022	08:21:02	24	1,994.50	XLON	xsqApDVE$od
28/02/2022	08:21:02	3	1,994.50	XLON	xsqApDVE$of
28/02/2022	08:34:26	77	1,994.50	XLON	xsqApDVEsQO
28/02/2022	08:13:03	107	1,994.00	BATE	xsqApDVEvpo
28/02/2022	08:13:03	101	1,994.00	XLON	xsqApDVEvpv
28/02/2022	08:13:03	12	1,994.00	XLON	xsqApDVEvpx
28/02/2022	08:22:16	79	1,994.00	XLON	xsqApDVE@1c
28/02/2022	08:22:16	89	1,994.00	XLON	xsqApDVE@6K
28/02/2022	08:22:16	89	1,994.00	BATE	xsqApDVE@6R
28/02/2022	08:14:25	91	1,994.00	XLON	xsqApDVEufe
28/02/2022	08:07:31	90	1,994.00	XLON	xsqApDVEbHf
28/02/2022	08:07:31	110	1,994.00	XLON	xsqApDVEbHk
28/02/2022	08:21:03	123	1,994.00	BATE	xsqApDVE$mo
28/02/2022	08:21:03	83	1,994.00	XLON	xsqApDVE$mz
28/02/2022	08:14:25	128	1,993.50	XLON	xsqApDVEufd
28/02/2022	08:07:31	89	1,993.50	XLON	xsqApDVEbHa
28/02/2022	08:17:41	114	1,993.00	CHIX	xsqApDVEz3J
28/02/2022	08:00:34	128	1,991.00	CHIX	xsqApDVEi4E
28/02/2022	08:00:35	75	1,990.50	BATE	xsqApDVEi5h
28/02/2022	08:00:30	22	1,990.50	BATE	xsqApDVEi05
28/02/2022	08:00:35	65	1,990.00	BATE	xsqApDVEi5j
28/02/2022	08:00:39	83	1,989.00	XLON	xsqApDVEivb
28/02/2022	08:19:36	146	1,987.50	BATE	xsqApDVEyqj
28/02/2022	08:19:36	6	1,987.50	XLON	xsqApDVEyqf
28/02/2022	08:19:36	110	1,987.50	XLON	xsqApDVEyqd
28/02/2022	08:19:36	115	1,987.50	CHIX	xsqApDVEyqh
28/02/2022	08:19:37	4	1,987.00	BATE	xsqApDVEyrC
28/02/2022	08:19:37	12	1,987.00	BATE	xsqApDVEyrE
28/02/2022	08:19:36	8	1,987.00	BATE	xsqApDVEyrT
28/02/2022	08:19:36	10	1,987.00	BATE	xsqApDVEyrV
28/02/2022	08:19:36	11	1,987.00	BATE	xsqApDVEyqX
28/02/2022	08:19:36	22	1,987.00	BATE	xsqApDVEyqZ
28/02/2022	08:19:36	79	1,987.00	XLON	xsqApDVEyrR
28/02/2022	08:19:36	13	1,987.00	BATE	xsqApDVEyqb
28/02/2022	08:19:37	114	1,987.00	XLON	xsqApDVEyrA
28/02/2022	08:18:00	159	1,985.50	XLON	xsqApDVEzos
28/02/2022	08:18:00	20	1,985.50	XLON	xsqApDVEzou
28/02/2022	08:00:25	200	1,981.50	XLON	xsqApDVEi9L

-- ENDS --

Enquiries:

Hikma Pharmaceuticals PLC

Peter SpeirsCompany Secretary

+44 (0)20 7399 2772

Susan RingdalEVP Strategy and Global Affairs

+44 (0)20 7399 2760

About Hikma

Hikma helps put better health within reach every day for millions of people around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,700 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit: www.hikma.com.

(LEI:549300BNS685UXH4JI75)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSVVLFLLLLXBBE

Date		Source	Headline
3rd Jun 2019	4:29 pm	RNS	Total Voting Rights
17th May 2019	4:09 pm	RNS	Result of AGM
17th May 2019	3:33 pm	RNS	Director/PDMR Shareholding
17th May 2019	7:00 am	RNS	Trading Statement
2nd May 2019	7:00 am	RNS	Total Voting Rights
1st May 2019	9:00 am	RNS	Hikma launches 100th injectable medicine in US
15th Apr 2019	4:26 pm	RNS	Director/PDMR Shareholding
15th Apr 2019	12:23 pm	RNS	Annual Financial Report
1st Apr 2019	5:42 pm	RNS	Total Voting Rights
1st Apr 2019	5:11 pm	RNS	Block listing Interim Review
18th Mar 2019	3:09 pm	RNS	Director/PDMR Shareholding
15th Mar 2019	10:32 am	RNS	Director/PDMR Shareholding
14th Mar 2019	9:14 am	RNS	Director/PDMR Shareholding
13th Mar 2019	1:50 pm	RNS	Director/PDMR Shareholding
13th Mar 2019	1:49 pm	RNS	Director/PDMR Shareholding
13th Mar 2019	7:00 am	RNS	Final Results
12th Mar 2019	7:00 am	RNS	Directorate Change
1st Mar 2019	4:51 pm	RNS	Total Voting Rights
28th Feb 2019	9:00 am	RNS	Hikma establishes partnership with Melinta in MENA
27th Feb 2019	1:26 pm	RNS	Block listing Interim Review
26th Feb 2019	11:08 am	RNS	Notice of Results
11th Feb 2019	10:11 am	RNS	Director/PDMR Shareholding
1st Feb 2019	3:43 pm	RNS	Total Voting Rights
29th Jan 2019	9:00 am	RNS	Hikma launches Mitomycin for Injection
3rd Jan 2019	9:00 am	RNS	Hikma announces agreement with Sciecure Pharma
19th Dec 2018	6:30 pm	RNS	Shire
10th Dec 2018	9:00 am	RNS	Hikma launches Clobazam
3rd Dec 2018	10:30 am	RNS	Total Voting Rights
27th Nov 2018	9:00 am	RNS	Hikma announces injectable licensing agreement
19th Nov 2018	9:00 am	RNS	Hikma launches Triazolam Tablets
13th Nov 2018	11:15 am	RNS	Holding(s) in Company
8th Nov 2018	9:44 am	RNS	Hikma announces agreement with Vectura
8th Nov 2018	7:00 am	RNS	Hikma announces agreement with Vectura
8th Nov 2018	7:00 am	RNS	Trading Statement
1st Nov 2018	12:39 pm	RNS	Total Voting Rights
16th Oct 2018	4:30 pm	RNS	Block listing Interim Review
1st Oct 2018	10:53 am	RNS	Total Voting Rights
1st Oct 2018	10:23 am	RNS	Holding(s) in Company
3rd Sep 2018	11:05 am	RNS	Total Voting Rights
30th Aug 2018	9:58 am	RNS	Holding(s) in Company
28th Aug 2018	12:45 pm	RNS	Holding(s) in Company
22nd Aug 2018	9:41 am	RNS	Director/PDMR Shareholding
15th Aug 2018	7:00 am	RNS	Half-year Report
23rd Jul 2018	9:00 am	RNS	Notice of Results
9th Jul 2018	9:00 am	RNS	Hikma enters licensing partnership with Perrigo
2nd Jul 2018	4:56 pm	RNS	Total Voting Rights
15th Jun 2018	3:24 pm	RNS	Director/PDMR Shareholding
8th Jun 2018	11:50 am	RNS	Director/PDMR Shareholding
4th Jun 2018	10:29 am	RNS	Director/PDMR Shareholding
4th Jun 2018	9:00 am	RNS	Hikma appoints Chief Transformation Officer

Latest Share Chat

Hikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

Login to your account

Quickpicks are a member only feature

Login to your account